Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olive Leaf Extracts in the Control of Cardiovascular Risk Factors
NCT05297110Phase 3Unknown
- Sponsor
- Université de Monastir
- Start
- Aug 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Université de Monastir. Primary endpoints: Rate of blood pressure reduction at 90 days and Rate of fasting glycemia level reduction at 90 days. Status: unknown.
Beyond the preview
Go deeper on NCT05297110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05297110.